<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對(duì)照品 > 標(biāo)準(zhǔn)物質(zhì) > 標(biāo)準(zhǔn)樣品 >
    1-(4-Nitrophenyl)cyclopentanecarbonitrile-d8
    產(chǎn)品基本信息
    產(chǎn)品編號(hào):N546636
    產(chǎn)品名稱:1-(4-Nitrophenyl)cyclopentanecarbonitrile-d8
    產(chǎn)品CAS:
    規(guī)格含量:250mg
    產(chǎn)品價(jià)格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號(hào): N546636
    名稱: 1-(4-Nitrophenyl)cyclopentanecarbonitrile-d8
    參考CAS號(hào): 91392-33-5
    分子式: C??H?D?N?O?
    分子量: 224.29
    種類: Building Blocks; Isotopic Labeled Analogues; Miscellaneous;
    應(yīng)用: 1-(4-Nitrophenyl)cyclopentanecarbonitrile-d8 is an intermediate used in the synthesis of Apatinib-d8 Hydrochloride (A726152), which is labelled Apatinib (A726150). Apatinib is an orally available, small molecule multitargeted tyrosine kinase inhibitor. Apatinib selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2). Apatinib functions by inhibiting VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue. Recent studies have shown that Apatinib enhances the efficacy of conventional chemotherapeutical drugs in side population (SP) cells and ABCB1-overexpressing leukemia cells.
    參考文獻(xiàn)


    2011-2018 信陽(yáng)萊耀生物科技有限公司 版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對(duì)照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對(duì)照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      小雪被房东的好爽文 | 欧美高潮喷水视频 | 大香蕉www | 成人三级视频在线观看 | 国产久操视频 |